ACPE Universal Activity Numbers 0221-9999-17-143-H04-P/T, 0221-9999-17-144-H04-P/T, 0221-9999-17-362-H04-P/T, 0221-9999-17-363-H04-P/T, 0221-9999-17-364-H04-P/T, 0221-9999-17-365-H04-P/T, 0221-9999-18-126-H04-P/T, 0221-9999-18-127-H04-P/T, 0221-9999-18-282-H04-P/T, 0221-9999-18-392-H04-P/T, and 0221-9999-19-007-H04-P/T have been assigned to these knowledge-based, home-study activities (initial release date for PBM 101 is 5-9-2017, PBM 102 is 6-16-2017, the 200 level courses is 8-25-2017, PBM 301 is 5-10-2018, PBM 302 is 6-15-2018, PBM 303 is 7-13-2018, PBM 304 is 10-12-18, and PBM 305 is 4-23-19). These activities are approved for a total of 10.0 contact hours (1.0 CEUs) in states that recognize ACPE providers. These CE activities are each provided for a fee. Completion of the evaluation for each activity is required to receive CE credit. No partial credit will be given.
PBM 101: Release Date 5-9-2017, Expiration Date 5-9-2020
PBM 102: Release Date 6-16-2017, Expiration Date 6-16-2020
PBM 201, 202, 203, and 204: Release Date 8-25-2017, Expiration Date 8-25-2020
PBM 301: Release Date 5-10-2018, Expiration Date 5-10-2021
PBM 302: Release Date 6-15-2018, Expiration Date 6-15-2021
PBM 303: Release Date 7-13-2018, Expiration Date 7-13-2021
PBM 304: Release Date 10-12-2018, Expiration Date 10-12-2021
PBM 305: Release Date 4-23-2019, Expiration Date 4-23-2022
It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed in CE activities. Rebecca Sedjo is a former employee of PBMI. Sharon Glave Frazee is a current employee of PBMI.
Please note: The information and views presented in this activity are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include the use of drugs and/or devices for unlabeled indications, which should be considered experimental. Participants are advised to consult manufacturer product information and the professional literature, and use professional judgment in applying the presented information in patient-care activities.
This activity is self-funded by Pharmacy Benefit Management Institute.